(NASDAQ: NAUT) Nautilus Biotechnology's forecast annual revenue growth rate of 350.36% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.15%.
Nautilus Biotechnology's revenue in 2026 is $190,000.On average, 6 Wall Street analysts forecast NAUT's revenue for 2026 to be $69,605,426, with the lowest NAUT revenue forecast at $62,355,059, and the highest NAUT revenue forecast at $86,183,600. On average, 6 Wall Street analysts forecast NAUT's revenue for 2027 to be $669,871,494, with the lowest NAUT revenue forecast at $491,586,926, and the highest NAUT revenue forecast at $988,773,083.
In 2028, NAUT is forecast to generate $2,433,756,140 in revenue, with the lowest revenue forecast at $1,933,006,837 and the highest revenue forecast at $3,180,108,023.